Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study
View abstract on PubMed
Summary
This summary is machine-generated.Lymphovascular invasion in invasive breast cancer is a poor prognostic factor impacting survival. Identifying lymphatic vessel invasion using markers like D2-40 improves diagnosis and predicts recurrence.
Area Of Science
- Oncology
- Pathology
- Cancer Research
Background
- Lymphovascular invasion (LVI) is a critical indicator in invasive breast cancer prognosis.
- Understanding LVI's role and refining its detection are essential for patient management.
Purpose Of The Study
- To evaluate the prognostic significance of LVI in invasive breast cancer.
- To assess the utility of specific vascular endothelial markers in classifying LVI.
Main Methods
- Analysis of 2124 invasive breast cancer patients' data (2012-2020).
- Statistical investigation of LVI correlation with clinicopathological features and survival (OS, DFS).
- Immunohistochemical staining (D2-40, CD34) to classify LVI and assess its relation to progression.
Main Results
- LVI strongly correlates with T stage, N stage, and nerve invasion.
- LVI is an independent poor prognostic factor for overall survival (OS) and disease-free survival (DFS), particularly in Luminal B, triple-negative, and Her-2+ subtypes.
- D2-40 positivity in LVI is linked to N stage and localized recurrence.
Conclusions
- LVI signifies aggressive features and is an independent poor prognostic factor in invasive breast cancer.
- Lymphatic vessel invasion impacts breast cancer recurrence and lymph node metastasis.
- Immunohistochemistry for LVI should be integrated into routine diagnostics.

